• 1
    Albertsen PC, Moore DF, Shih WC, Lin Y, Li H, Lu-Yao GL. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol. 2011;29:13351341.
  • 2
    Emory University, American Cancer Society. Accessed May 17, 2013.
  • 3
    Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004;22:21412149.
  • 4
    Hamilton AS, Albertsen PC, Johnson TK, et al. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int. 2011;107:576584.
  • 5
    Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888897.
  • 6
    D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969974.
  • 7
    Merrick GS, Butler WM, Wallner KE, et al. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005;61:3243.
  • 8
    Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:12501261.
  • 9
    Nguyen PL, Gu XM, Lipsitz SR, et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol. 2011;29:15171524.
  • 10
    Falit BP, Gross CP, Roberts KB. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys. 2010;76:12851288.
  • 11
    Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007;178(3 pt 2):S14S19.
  • 12
    Spencer BA, Fung CH, Wang M, Rubenstein LV, Litwin MS. Geographic variation across veterans affairs medical centers in the treatment of early stage prostate cancer. J Urol. 2004;172(6 pt 1):23622365.
  • 13
    Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28:11171123.
  • 14
    Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS. Characteristics of urologists predict the use of androgen deprivation therapy for prostate cancer. J Clin Oncol. 2007;25:53595365.
  • 15
    Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O. SAS® for Mixed Models. 2nd ed. Cary, NC: SAS Institute Inc; 2006.
  • 16
    Snijders TAB, Bosker R. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Thousand Oaks, CA: Sage; 1999.
  • 17
    Krupski TL, Kwan L, Afifi AA, Litwin MS. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol. 2005;23:78817888.
  • 18
    McNaughton Collins M, Barry MJ, Zietman A, et al. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. Urology. 2002;60:628633.
  • 19
    Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004;64:11711176.
  • 20
    Underwood W 3rd, Jackson J, Wei JT, et al. Racial treatment trends in localized/regional prostate carcinoma: 1992–1999. Cancer. 2005;103:538545.
  • 21
    Jha AK, Li Z, Orav EJ, Epstein AM. Care in US hospitals–the Hospital Quality Alliance program. N Engl J Med. 2005;353:265274.
  • 22
    Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:14581465.
  • 23
    Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(suppl 8):IV-3IV-18.
  • 24
    The Henry J. Kaiser Family Foundation. Medicare Chartbook, 2010. Accessed May 17, 2013.
  • 25
    Zeliadt SB, Moinpour CM, Blough DK, et al. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care. 2010;16:e121e130.
  • 26
    Hershman DL, Buono D, McBride RB, Tsai WY, Neugut AI. Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women. Cancer. 2009;115:38483857.
    Direct Link:
  • 27
    Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst. 2006;98:839845.
  • 28
    Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG. The unreliability of individual physician “report cards” for assessing the costs and quality of care of a chronic disease. JAMA. 1999;281:20982105.
  • 29
    Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006;106:18651874.
  • 30
    Shen J, Andersen R, Brook R, Kominski G, Albert PS, Wenger N. The effects of payment method on clinical decision-making: physician responses to clinical scenarios. Med Care. 2004;42:297302.
  • 31
    Mitchell JM, Sass TR. Physician ownership of ancillary services: indirect demand inducement or quality assurance? J Health Econ. 1995;14:263289.
  • 32
    Mitchell JM. Do financial incentives linked to ownership of specialty hospitals affect physicians' practice patterns? Med Care. 2008;46:732737.
  • 33
    Gazelle GS, Halpern EF, Ryan HS, Tramontano AC. Utilization of diagnostic medical imaging: comparison of radiologist referral versus same-specialty referral. Radiology. 2007;245:517522.
  • 34
    Mitchell JM. Effect of physician ownership of specialty hospitals and ambulatory surgery centers on frequency of use of outpatient orthopedic surgery. Arch Surg. 2010;145:732738.
  • 35
    Mitchell JM. Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection. Health Aff (Millwood). 2012;31:741749.
  • 36
    Nallamothu BK, Rogers MA, Chernew ME, Krumholz HM, Eagle KA, Birkmeyer JD. Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries. JAMA. 2007;297:962968.
  • 37
    Mitchell JM, Sunshine JH. Consequences of physicians ownership of health care facilities-joint ventures in radiation therapy. N Engl J Med. 1992;327:14971501.